Category: Finance
Tech Sector Hit by Guidance Woes Post-Earnings
The after-hours stock market painted a grim picture for several tech giants, as investor reactions to company earnings reports and future outlooks led to sharp [more…]
Retail and Tech Stocks Take Center Stage in Premarket Moves
In the dynamic landscape of premarket stock movements, notable companies have made headlines with significant shifts in their share prices. Target Corporation emerges as a [more…]
Market Highlights: Microsoft’s new AI chip, why divvy stocks aren’t a sure thing, and 5 small caps to watch
ASX set to fall despite a modest rally on Wall Street Microchip stocks fell as Microsoft unveiled its new custom AI chip Janus Henderson says [more…]
Australian regulators greenlight offshore carbon capture and storage
Key legislative changes passed to facilitate the injection and transportation of CO2 in Australian waters Provides Pilot with a clear regulatory pathway for the Mid [more…]
US FDA grants Argenica Orphan Drug designation to treat ‘devastating condition’ in newborns
US FDA grants ARG-007 orphan drug designation to treat hypoxic ischaemic encephalopathy No therapeutic drug on the market to protect brain cells following hypoxic ischaemic [more…]
Thick, shallow and high grade: Azure’s Target Area 3 at Andover is jam-packed with lithium
Over 500m of thick, high-grade lithium is confirmed at the APOOO3/APOOO4 pegmatite over 500m strike >1km and 450m of down-dip visual spodumene observed at the [more…]
High demand means Ionic Rare Earths magnet recycling demo plant will soon operate around the clock
Ionic Rare Earths’ magnet recycling demonstration plant is ramping up to move to 24/7 continuous operation from early January 2024 This is a result of [more…]
PETER STRACHAN: REE prices are rising again, but who’s winning the ASX race to production?
Peter Strachan is a capital markets veteran, resources analyst and lover of the oil and gas game. The brains behind the popular weekly StockAnalysis investment [more…]
Dr Boreham’s Crucible: Nanosonics is testing more patience than ever. Is it a case of ‘relax and it won’t hurt a bit’?
Reflecting on his 10 years as CEO of the medical device play – a milestone achieved last month – Michael Kavanagh says the numbers tell [more…]
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at [more…]
